Adding Gemcitabine to Paclitaxel/Carboplatin Combination Increases Survival in Advanced Non–Small-Cell Lung Cancer: Results of a Phase II-III Study - Concepedia

Concepedia

Publication | Closed Access

Adding Gemcitabine to Paclitaxel/Carboplatin Combination Increases Survival in Advanced Non–Small-Cell Lung Cancer: Results of a Phase II-III Study

53

Citations

24

References

2006

Year

Adriano Paccagnella, Francesco Oniga, Alessandra Bearz, Adolfo Favaretto, M. Clerici, Fausto Barbieri, Alberto Riccardi, Antonio Chella, Umberto Tirelli, Giovanni Luca Ceresoli,

Journal of Clinical Oncology

Abstract

The PCG regimen offers a significant survival advantage over PC in advanced NSCLC, making PCG a treatment option for advanced NSCLC patients.

References

	Year	Citations

Page 1